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Abstract
Meal intake leads to a significant and prolonged increase in cardiac output to supply the splanchnic vasculature. A meal is associated with sympathetic
activation of the cardiovascular system, and food ingestion is correlated with an increase in heart rate, an increase in cardiac stroke volume, and
QTc interval shortening for up to 7 hours. Given the complexity of the system, one or several of many mechanisms could explain this observation.
The shortening of the QTc interval was correlated with a rise of C-peptide following food ingestion, but the mechanisms by which C-peptide may
be involved in the modulation of cardiac repolarization are still unknown. This shortening of the myocardial action potential caused by the ingestion
of food was further investigated in the present study by measuring the QRS, J-Tpeak, and Tpeak-Tend intervals in search of further clues to better
understand the underlying mechanisms. A retrospective analysis was conducted based on data collected in a formal thorough QT/QTc study in which
32 subjects received a carbohydrate-rich “continental” breakfast,moxifloxacin without food,and moxifloxacin with food.We assessed the effect of food
on T-wave morphology using validated algorithms for measurement of J-Tpeak and Tpeak-Tend intervals. Our findings demonstrate that a standardized
meal significantly shortened J-Tpeak for 4 hours after a meal and to a much lesser extent and shorter duration (up to 1 hour) prolonged the Tpeak-Tend
and QRS intervals. This suggests that the QTc shortening occurs mainly during phase 2 of the cardiac action potential. As there was no corresponding
effect on Tpeak-Tend beyond the first hour, we conclude that a meal does not interfere with the outward correcting potassium channels but possibly
with Ca2+ currents. An effect on mainly Ca2+ aligns well with our understanding of physiology whereby an increase in stroke volume, as observed
after a meal, is associated with changes in Ca2+ cycling in and out of the sarcoplasmic reticulum during cardiac myocyte contraction.
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The effect of food onQTc has been reported in different
studies.1–3 A standardized meal induces a decrease in
the heart rate corrected QTcF of 6 to 8 milliseconds,
1.5 to 4 hours after food intake correlated with an
increase in heart rate.1 This effect was shown to be well
reproducible in terms of both magnitude of the effect
and time course.4
The effects of food leading to a change in QTc are
the result of physiological effects on the heart and
not the result of drug-induced ion channel blockade,
which makes food challenge an attractive alternative
to moxifloxacin as a positive control in thorough elec-
trocardiographic studies. The effect of food on QTcF
to demonstrate assay sensitivity in early-stage clinical
studies has been recognized as a valuable tool to in-
crease confidence in the results of exposure-response
analyses of early phase I studies to request a waiver of
the thorough QT/QTc study regulatory requirement.5
However, the underlying mechanisms of such effect
remain unclear.
C-peptide, which is released in equimolar amounts
to insulin but stays in circulation for longer periods due
to a longer circulatory elimination half-life has emerged
as a potential effector for the QTc shortening observed
following ingestion of a meal. It appears to antagonize
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the QT prolonging effects of glucose,6 while insulin
at physiological levels was shown to have no effect on
QTc.7 In patients with type 1 diabetes with neuropathy,
administration of C-peptide was also shown to shorten
the QTc.8
The physiological response to a meal includes a
significant increase in cardiac output (CO) to supply the
splanchnic vasculature. Work by other groups suggests
that the increase in CO is the result of a heart rate
increase and an increase in stroke volume. The increase
in CO results from an autonomic response, and elevated
levels of norepinephrine have been observed during
the postprandial period.9 However, the QTc shortening
effect of food goes well beyond the postprandial pe-
riod, during which elevated levels of catecholamine are
found. This suggests that other mechanisms may play a
role in regulating repolarization.
Johannesen et al10 hypothesized that the electro-
cardiogram (ECG) can differentiate the effects of ion
channel drug blockade by separate analysis of early
repolarization (global J-Tpeak) and late repolariza-
tion (global Tpeak-Tend). Results have shown that hu-
man Ether-a`-go-go-Related Gene potassium channel
block equally prolongs J-Tpeak and Tpeak-Tend intervals,
whereas the addition of calcium or late sodium cur-
rent block preferentially shortens the J-Tpeak interval.
Following a similar approach, in this study, we aim to
better understand which ion channels may be involved
in the meal response and better characterize the ECG
signature and impact of food on T-wave morphology.
Materials and Methods
Study Design
The study was approved by the local National Health
Service Ethics Committee (London Surrey-Borders,
UK) and the Medicines and Healthcare Products Reg-
ulatory Authority and was conducted in accordance
with Good Clinical Practice and the Declaration of
Helsinki. The study population consisted of 32 healthy,
nonsmoking, white (13; 7 males and 6 females) and
Asian (19; 11 males and 8 females) subjects. The study
was designed as a single-center, randomized, placebo-
and positive-controlled, crossover study. Eligible sub-
jects were randomized to 1 of 8 sequences of the
treatments, insulin euglycemic clamp, a carbohydrate-
rich “continental” breakfast, a calorie-reduced break-
fast, a single dose of moxifloxacin 400 mg, a single
dose of moxifloxacin 400 mg with a carbohydrate-
rich continental breakfast, and placebo. The calorific
content of the carbohydrate-rich continental breakfast
and calorie-reduced breakfast, as well as the ECG
assessments, are described in Ta¨ubel et al.7 Breakfasts
were provided 30 minutes prior to the scheduled dosing
time (time zero) and were to be fully eaten by 10
minutes before dosing. Subjects were provided with
lunch at 7 hours after time zero. The retrospective
analysis reported here is based on the data from the fol-
lowing treatment sequences: a carbohydrate-rich con-
tinental breakfast, moxifloxacin 400 mg, moxifloxacin
400 mg administered with a carbohydrate-rich con-
tinental breakfast, and placebo; the other arms are
described elsewhere.7
Subjects participating in the study attended for
screening and 2 treatment periods (periods 1 and 2)
separated by a 3-day washout interval. Each period
consisted of a baseline ECG day (day –1) where no
treatments were administered and only standardized
meals were given, and treatment days (days 1, 2,
and 3).7 The ECG and samples for pharmacokinet-
ics (PK)/pharmacodynamics analysis on the treatment
days were taken at the corresponding clock time points
as on the baseline day.
Statistical Analyses
ECG Recording and Data Processing. Twelve-lead ECGs
were recorded at Richmond Pharmacology Ltd. using
a MAC1200 R© (500-Hz sampling frequency, 4.88-μV
amplitude least significant bit resolution, GE Health-
care, Milwaukee, Wisconsin) recorder connected via a
fixed network connection to the MUSER© Cardiology
Information System. ECG recordings were made at
the following time points: before the dose (time zero)
and 0.25, 0.5, 0.75, 1.0, 1.5, 2.0, 2.5, 3.0, 3.5, 4.0,
and 6.0 hours after the dose on all days 3 after the
subjects had been resting in a supine position for at
least 10 minutes. At each time point, the ECGs were
recorded in triplicate and performed at approximately
1-minute intervals. Each ECG recording lasted 10 sec-
onds. Repeat ECGs were performed until at least three
10-second ECG recordings per scheduled time point
met the predefined quality criteria to enable reading
and analyzing at least 5 complexes per derivation. All
ECGs recorded during the study were stored electron-
ically at the MUSE information system. Data were
processed by the Department of Health Science and
Technology of the Faculty of Medicine, University of
Aalborg (Denmark), using the commercially available
GEHealthcareMarquette 12SLECGanalysis program
and the US Food and Drug Administration 510(k)-
cleared GE research package QT GuardPlus, which
uses validated algorithms for measurement.11,12 This
software uses the simultaneous vector magnitude of
all 12 leads to determine the onset and offset of the
QRS complex, as well as the offset of the T wave. The
vector magnitude is a global single-lead representation
of all 12 leads that did not display a biphasic (pos/neg
or neg/pos) T wave. In cases with clear biphasic T
waves in some of the 12 leads, the vector magnitude
representation may have displayed 2 obvious positive
peaks in the T wave. In these cases, the algorithm used
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the second peak of the T wave, which is closest to the
end of the T wave. The end of the T wave is determined
by the method of small windows.11,12
Heart Rate Correction of J-Tpeak and Baseline Correction.
For accounting for the influence of heart rate (HR) on
the T wave, a correction to J-Tpeak was applied10,13,14 as
HR variation is expected only for early repolarization
(J-Tpeak). A previous study including a pooled analysis
of subjects from 34 thorough QT studies, has shown
that at resting HRs Tpeak-Tend exhibits minimal HR
dependency and only J-Tpeak, and QT showed a sub-
stantial (>10%) HR variation.15
In analogy to the situation with QTc, a study-specific
correction was considered necessary, since both J-Tpeak
and HR are affected.16 The correction term β of 0.51
was derived from a linear mixed model regressing the
logarithmic transformation of J-Tpeak on the logarith-
mic transformation of RR, using the predose samples
only. This correction term is further validated by the
small difference with the correction term reported by
Johannesen et al.10 Furthermore, the sum of the HR-
corrected J-Tpeak, QRS interval, and Tpeak-Tend gave an
estimated QT interval that, on average, differed from
QTcF by only 0.74 milliseconds, with an upper 1-sided
90% confidence interval (CI) of only 0.79 milliseconds.
The baseline-corrected variables (QRS, J-
TpeakcS, andTpeak-Tend) were obtained by subtracting
the predose value of QRS, the HR-corrected J-Tpeak,
and Tpeak-Tend, calculated by time point, subject, and
period, from the postdose corrected value, matched by
subject, time point, and period.
Mixed Models. The time point analysis was based on
the change of QRS, J-TpeakcS, and Tpeak-Tend from the
time-matched baseline (outcome variables: QRS, J-
TpeakcS, and Tpeak-Tend).
The time point analysis involved 1 mixed model
for each outcome variable (QRS, J-TpeakcS, and
Tpeak-Tend), with the interaction between treatment
and time point as fixed effect and scaled baseline
as covariate; the random term included correlated
intercepts and slopes for the baseline. This analysis
aimed to ascertain whether the time course of the
ECGmarkers differed between treatment groups (mox-
ifloxacin fasted, moxifloxacin combined with a high-
carbohydrate breakfast, and a carbohydrate breakfast
vs placebo).
The mixed models were fitted with the package
lmerTest (version 3.0-0). Analyses were carried out
using R (version 3.4.3; R Core Team, 2017).
Results
This study included 32 subjects. There were no unex-
pected treatment-related adverse events.
Confirmation of Assay Sensitivity
As previously described,17 the largest QTcF change
from baseline after a 400-mg oral dose of moxifloxacin
in the fed state was observed at 4 hours with a peak
value of 11.6 milliseconds (2-sided 90%CI, 9.1–14.1),
while the largest QTcF change observed in the fasted
state was 14.4 milliseconds (90%CI, 11.9–16.8) and
occurred at 2.5 hours after the dose. For the conti-
nental breakfast, the maximum QTcF shortening was
observed at 3.5 hours after the dose with a value of
7.9 milliseconds (2-sided 90%CI, –10.4 to –5.5).7
Time Point Analysis
The descriptive statistics ofQT, QRS, J-TpeakcS,
and Tpeak-Tend (averages and 90%CIs) are presented
in Figure 1. The mixed-model analysis by time point for
each outcome variable is described below.
QRS Interval. QRS did not significantly change
from baseline in neither group (Table 1). A high-
carbohydrate breakfast and moxifloxacin with a high-
carbohydrate breakfast showed an immediate, small,
short-lived positive difference from placebo 15 to
30minutes after time zero, with a difference between the
estimates of 2.72 milliseconds at 15 minutes (P < .01)
and 2.40 milliseconds at 30 minutes (P < .05) for a
high-carbohydrate breakfast, and a difference of 3.04
milliseconds at 15 minutes (P < .001) for moxifloxacin
with a high-carbohydrate breakfast (Table 2). This
suggests that the change in QRS is associated with the
meal and not withmoxifloxacin, as moxifloxacin has no
effect when given fasted.
J-Tpeakcs Interval. A pronounced shortening of J-
TpeakcS was observed with the ingestion of a stan-
dardized carbohydrate-rich breakfast. The estimated
changes of J-TpeakcS with food were consistently and
significantly different from baseline starting 15 minutes
after time zero (–9.52 milliseconds; 90%CI, –14.93 to
–3.34) up to 4 hours after the dose (–9.39 millisec-
onds; 90%CI, –15.33 to –4.04), denoting 45 minutes to
4.5 hours after starting a meal, as the meal was started
30 minutes before dosing/time zero (Table 3). The
estimate of J-TpeakcS with moxifloxacin combined
with food also significantly shortened until 2.5 hours
after the dose (–6.55 milliseconds; 90%CI, –12.89 to
–0.14), started to lengthen up to 6 hours, and ex-
ceeded placebo only 6 hours after the dose, showing
a different tendency of the one observed for breakfast
alone (Table 4). It is important to note that the PK of
moxifloxacin is affected by a predose meal, leading to
lower concentrations of moxifloxacin in plasma for the
first 3 hours. The difference becomes small from the
4-hour time point onward.
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Figure 1. Averages by time point and treatment group of the observed values of QT (A), QRS (B), J-TpeakcS (C), and Tpeak-Tend (D), as
measured from the participants. The 90% confidence intervals are shown as vertical lines.
Following administration of moxifloxacin in the
fasted state, J-TpeakcS increased steadily over time,
with significant changes starting from 30 minutes
(5.80 milliseconds; 90%CI, 0.26–11.28). The estimated
changes of J-TpeakcS with moxifloxacin were con-
sistently and significantly different from placebo from
45 minutes after dosing up to 6 hours (Table 4).
Tpeak-Tend Interval. Moxifloxacin administered in a
fasting condition clearly prolonged Tpeak-Tend. The
increase of Tpeak-Tend was significantly higher than
baseline from 2.5 hours (5.36 milliseconds; 90%CI,
1.02–9.49) up to 6 hours (7.50 milliseconds; 90%CI,
2.82–11.46). However, if given after breakfast, it was
not associated with Tpeak-Tend prolongation until
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Table 1. Output of the Mixed Model on QRS (Contrasts on Baseline)
Parameter Estimate
Standard
Error
Degrees of
Freedom (df) T Value P Value 5%CI 95%CI
Baseline −5.93 0.28 34.04 −21.24 < .001 −6.44 −5.52
Treatment Time point
Placebo H 0.25 −0.63 1.24 41.28 −0.51 .61 −2.71 1.54
H 0.5 −0.27 1.24 41.18 −0.22 .83 −2.19 1.99
H 0.75 −0.2 1.24 41.19 −0.16 .87 −1.85 1.74
H 1 −0.59 1.24 41.19 −0.47 .64 −2.5 1.55
H 1.5 −1.18 1.24 41.12 −0.95 .35 −3.33 0.92
H 2 −1.07 1.24 41.24 −0.86 .40 −3.07 1.15
H 2.5 −0.67 1.24 41.29 −0.54 .59 −2.65 1.75
H 3 −0.82 1.24 41.11 −0.66 .51 −2.67 1.06
H 3.5 −0.12 1.24 41.12 −0.10 .92 −1.96 2.13
H 4 −1.15 1.24 41.01 −0.92 .36 −3.29 1.18
H 6 0.55 1.24 41.29 0.44 .66 −1.43 2.48
Moxifloxacin H 0.25 −1.25 1.24 41.41 −1.00 .32 −3.26 0.86
H 0.5 −0.15 1.24 41.21 −0.12 .91 −2.04 1.94
H 0.75 −0.17 1.24 41.38 −0.14 .89 −2.14 2.40
H 1 −0.70 1.25 41.52 −0.56 .58 −2.66 1.41
H 1.5 −1.33 1.24 41.41 −1.07 .29 −3.43 0.69
H 2 −0.20 1.24 41.34 −0.16 .87 −2.57 2.11
H 2.5 −1.52 1.24 41.34 −1.23 .23 −3.70 0.57
H 3 −0.39 1.24 41.31 −0.31 .76 −2.41 1.62
H 3.5 −0.93 1.24 41.32 −0.75 .46 −2.86 0.94
H 4 −1.37 1.24 41.43 −1.10 .28 −3.06 0.74
H 6 0.34 1.24 41.3 0.27 .79 −2.05 2.34
High-carbohydrate
breakfast
H 0.25 1.50 1.24 41.29 1.20 .24 −0.38 3.33
H 0.5 1.53 1.24 41.17 1.24 .22 −0.16 3.72
H 0.75 1.34 1.24 41.36 1.07 .29 −0.48 3.40
H 1 −0.31 1.24 41.35 −0.25 .80 −2.48 2.16
H 1.5 −0.10 1.24 41.37 −0.08 .93 −2.03 2.33
H 2 −1.15 1.24 41.36 −0.92 .36 −3.01 1.24
H 2.5 −1.12 1.24 41.24 −0.90 .37 −3.57 0.82
H 3 −0.92 1.24 41.49 −0.74 .46 −3.09 1.00
H 3.5 −0.90 1.24 41.39 −0.72 .48 −2.87 1.91
H 4 −0.89 1.24 41.46 −0.72 .48 −3.05 1.26
H 6 0.62 1.24 41.21 0.50 .62 −1.5 3.05
Moxifloxacin +
high-carbohydrate
breakfast
H 0.25 2.41 1.24 41.17 1.94 .06 0.47 4.73
H 0.5 1.18 1.24 41.14 0.95 .35 −1.02 3.60
H 0.75 1.02 1.24 41.15 0.82 .42 −1.07 3.28
H 1 0.44 1.24 41.03 0.36 .72 −1.36 3.09
H 1.5 −1.55 1.24 41.08 −1.25 .22 −3.59 0.65
H 2 −0.02 1.24 41.27 −0.01 .99 −2.09 2.12
H 2.5 −1.60 1.24 41.18 −1.29 .20 −3.89 0.88
H 3 −1.52 1.24 41.28 −1.22 .23 −3.69 0.20
H 3.5 −0.80 1.24 41.20 −0.65 .52 −2.93 1.86
H 4 −2.17 1.24 41.03 −1.75 .09 −4.41 0.01
H 6 −0.69 1.24 41.20 −0.55 .58 −2.54 1.35
6 hours after the dose (6.47 milliseconds; 90%CI, 2.32–
10.05), indicating that the addition of food reduced the
effects of moxifloxacin (Table 5). The linear contrasts
with placebo estimates confirm this pattern, showing
consistently higher estimates of Tpeak-Tend with mox-
ifloxacin than placebo up to 6 hours and nonsignificant
differences when food is added until 2 hours (Table 6).
This could be the result of changes in the PK profile
or a true increase of the moxifloxacin-induced QT
prolongation.
Discussion
In this study, we retrospectively assessed the effects
of food on the QRS, J-Tpeak, and Tpeak-Tend intervals
by using data from a previously published thorough
QT/QTc study in which moxifloxacin was administered
as a positive control confirming assay sensitivity of the
study.7,17
Moxifloxacin is known as a blocker of the inward
rectifying potassium channels Ikr and Iks.18 After a
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Table 2. Linear Contrasts Between Placebo and Treatment Groups Derived From the Mixed Model on QRS
Parameters
Contrast
Time
Point Group Estimate
Standard
Error T Value P Value
Placebo H 0.25 High-carbohydrate breakfast 2.72 0.70 3.90 <.01
Moxifloxacin −0.02 0.70 −0.04 >0.99
Moxifloxacin + high-carbohydrate breakfast 3.04 0.70 4.38 <.001
H 0.5 High-carbohydrate breakfast 2.40 0.70 3.45 <.05
Moxifloxacin 0.72 0.70 1.03 >0.99
Moxifloxacin + high-carbohydrate breakfast 1.45 0.69 2.09 .66
H 0.75 High-carbohydrate breakfast 2.13 0.70 3.06 .06
Moxifloxacin 0.62 0.70 0.89 >0.99
Moxifloxacin + high-carbohydrate breakfast 1.81 0.69 2.61 .24
H 1 High-carbohydrate breakfast 0.87 0.70 1.24 .99
Moxifloxacin 0.48 0.70 0.69 >0.99
Moxifloxacin + high-carbohydrate breakfast 1.03 0.70 1.48 .98
H 1.5 High-carbohydrate breakfast 0.48 0.70 0.69 >0.99
Moxifloxacin −0.15 0.70 −0.22 >0.99
Moxifloxacin + high-carbohydrate breakfast −0.97 0.70 −1.39 .99
H 2 High-carbohydrate breakfast −0.08 0.70 −0.12 >0.99
Moxifloxacin 0.87 0.70 1.24 .99
Moxifloxacin + high-carbohydrate breakfast 1.05 0.69 1.51 .97
H 2.5 High-carbohydrate breakfast −0.45 0.70 −0.64 >0.99
Moxifloxacin −0.85 0.70 −1.22 .99
Moxifloxacin + high-carbohydrate breakfast −0.93 0.70 −1.34 .99
H 3 High-carbohydrate breakfast −0.69 0.70 −0.98 >0.99
Moxifloxacin −0.16 0.70 −0.23 >0.99
Moxifloxacin + high-carbohydrate breakfast −0.7 0.70 −1.00 >0.99
H 3.5 High-carbohydrate breakfast −0.18 0.70 −0.26 >0.99
Moxifloxacin −0.8 0.70 −1.15 .99
Moxifloxacin + high-carbohydrate breakfast −0.68 0.70 −0.97 >0.99
H 4 High-carbohydrate breakfast 1.44 0.70 2.05 .69
Moxifloxacin 0.96 0.70 1.37 .99
Moxifloxacin + high-carbohydrate breakfast −1.02 0.70 −1.47 .98
H 6 High-carbohydrate breakfast 0.66 0.70 0.95 >0.99
Moxifloxacin 0.38 0.70 0.55 >0.99
Moxifloxacin + high-carbohydrate breakfast −1.24 0.70 −1.78 .89
single 400-mg oral dose has previously been reported
to cause a modest (10–14 milliseconds) prolongation
of the QT interval, J-Tpeak, and Tpeak-Tend intervals.19
Our results from this study are aligned with this ECG
signature.
Interactions of feeding and moxifloxacin-induced
QTcF prolongation not secondary to changes in the PK
profile were first reported by Bloomfield et al.20 Our
previous analysis of the QTcF interval had shown an
apparent reduction in QTcF prolongation when mox-
ifloxacin was given after breakfast,17 but it is unclear
howmuch of that effect is attributable to the altered PK
profile that occurs when moxifloxacin is given after a
meal. An interaction between the QT shortening effects
of food on the cardiac action potential and the QT
prolonging block of Ikr/Iks after moxifloxacin may
exist even if the underlying mechanisms were different.
The main objective of this study was to further
investigate the effects of a meal on the ECG uti-
lizing an automated algorithm allowing the assess-
ments of change to QRS, J-Tpeak, and Tpeak-Tend. This
analysis revealed that a meal leads to a prompt, lasting,
and significant shortening of J-Tpeak in both male
and female volunteers. We did not see effects on
QRS and Tpeak-Tend beyond a small prolongation of
both intervals during the first hour after starting a
meal.
It is well recognized that eating a meal is associated
with changes in the cardiovascular system due to the
increase in blood flow to the splanchnic vascular bed.
The increase in CO is delivered by an increase of HR
and stroke volume. In our studies, we typically find
HR increases of 8 beats/min, which gradually return
to baseline over 4 hours after a meal.1,7 In healthy
subjects, the CO showed increases depending on type
of meal, age, and sex.21,22 The composition of a meal
may play an important role, as high-carbohydratemeals
were shown to be accompanied by a prolonged rise of
CO: 32% compared with a rise of 22% after ingestion
of high-fat meals.21 In addition to the differing effects
of meal composition on CO, there are different pat-
terns of change in peripheral hemodynamics. High-fat
Ta¨ubel et al 7
Table 3. Output of the Mixed Model of J-Tpeak (Contrasts on Baseline)
Parameter Estimate
Standard
Error
Degrees of
Freedom (df) T Value P Value 5%CI 95%CI
Baseline −16.41 1.32 31.41 −12.43 <.001 −18.81 −14.02
Treatment Time point
Placebo H 0.25 −0.35 3.33 33.37 −0.11 .92 −5.85 5.68
H 0.5 −0.1 3.34 33.49 −0.03 .98 −5.68 5.72
H 0.75 −0.29 3.34 33.75 −0.09 .93 −6.13 5.53
H 1 0.47 3.34 33.52 0.14 .89 −5.13 6.58
H 1.5 −0.34 3.34 33.5 −0.1 .92 −5.9 5.05
H 2 −0.37 3.34 33.58 −0.11 .91 −5.91 5.46
H 2.5 −1.27 3.34 33.74 −0.38 .71 −6.87 4.98
H 3 −1.25 3.34 33.56 −0.38 .71 −6.87 3.68
H 3.5 −2.07 3.33 33.44 −0.62 .54 −6.87 4.08
H 4 −1.58 3.33 33.47 −0.47 .64 −7.41 4.81
H 6 −4.69 3.34 33.48 −1.41 .17 −10.09 1.14
Moxifloxacin H 0.25 1.16 3.33 33.41 0.35 .73 −4.49 6.9
H 0.5 5.8 3.34 33.64 1.74 .09 0.26 11.28
H 0.75 6.7 3.35 33.9 2 .05 0.91 13.07
H 1 8.01 3.34 33.75 2.4 <.05 2.00 13.87
H 1.5 7.23 3.34 33.83 2.16 <.05 1.41 13.68
H 2 6.62 3.34 33.6 1.98 .06 0.33 12.24
H 2.5 7.53 3.34 33.81 2.25 <.05 1.44 14.15
H 3 6.3 3.34 33.7 1.89 .07 0.50 11.46
H 3.5 5.69 3.34 33.56 1.71 .1 0.63 11.35
H 4 5.94 3.34 33.6 1.78 .08 0.26 11.31
H 6 1.4 3.34 33.71 0.42 .68 −4.73 6.93
High-carbohydrate
breakfast
H 0.25 −9.52 3.34 33.6 −2.85 <.01 −14.93 −3.34
H 0.5 −9.48 3.34 33.61 −2.84 <.01 −14.35 −3.27
H 0.75 −9.78 3.34 33.6 −2.93 <.01 −15.67 −4.19
H 1 −8.58 3.34 33.82 −2.57 <.05 −14.14 −2.19
H 1.5 −9.38 3.34 33.76 −2.81 <.01 −15.21 −3.4
H 2 −9.32 3.34 33.62 −2.79 <.01 −14.45 −3.36
H 2.5 −10.28 3.34 33.65 −3.08 <.01 −16.6 −5.27
H 3 −9.1 3.34 33.62 −2.73 <.05 −15.18 −3.82
H 3.5 −10.11 3.34 33.69 −3.03 <.01 −15.42 −3.16
H 4 −9.39 3.34 33.63 −2.81 <.01 −15.33 −4.04
H 6 −3.85 3.34 33.68 −1.15 .26 −9.98 2.82
Moxifloxacin +
high-carbohydrate
breakfast
H 0.25 −10.65 3.34 33.55 −3.19 <.01 −16.32 −5.01
H 0.5 −11.07 3.33 33.46 −3.32 <.01 −17.7 −5.21
H 0.75 −9.67 3.33 33.45 −2.9 <.01 −15.33 −3.74
H 1 −9.72 3.34 33.59 −2.91 <.01 −15.04 −3.71
H 1.5 −7.38 3.33 33.44 −2.21 <.05 −12.74 −1.28
H 2 −7.01 3.34 33.6 −2.1 <.05 −12.56 −1.04
H 2.5 −6.55 3.34 33.58 −1.96 .06 −12.89 −0.14
H 3 −5.08 3.33 33.48 −1.52 .14 −11.07 −0.13
H 3.5 −4.69 3.34 33.57 −1.4 .17 −11.02 1.64
H 4 −1.61 3.34 33.5 −0.48 .63 −7.39 3.76
H 6 1.72 3.33 33.45 0.52 .61 −3.8 6.64
meals increased the postprandial superior mesenteric
blood flow of 121%, compared with 87% for the high-
carbohydrate meal.23
Plasma noradrenaline levels were shown to increase
after a high-carbohydrate meal, while levels were
virtually unchanged after a high-fat meal,24 although
we found little difference on QTcF between carbohy-
drate meals and meals with a higher fat content.7 The
ingestion of a meal was associated with an increase
in cardiac sympathetic activity in young subjects,25,26
while healthy elderly subjects do not increase cardiac
sympathetic activity after meal ingestion.27 Activation
of the sympathetic nervous system plays a major
role in maintaining cardiovascular homeostasis by
increasing inotropy, chronotropy, and lusitropy. These
changes are mediated by activation of the β-adrenergic
receptor signaling pathway, leading to protein kinase A
activation and phosphorylation of intracellular
proteins. A key target of protein kinase A is the
sarcolemmal L-type Ca2+ channel, which, when
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Table 4. Linear Contrasts Between Placebo and Treatment Groups Derived From the Mixed Model on J-Tpeak
Parameters
Contrast Timepoint Group Estimate
Standard
Error T Value P Value
Placebo H 0.25 High-carbohydrate breakfast −9.16 1.36 −6.74 <.001
Moxifloxacin 1.51 1.35 1.11 .9998
Moxifloxacin + high-carbohydrate breakfast −10.29 1.35 −7.6 <.001
H 0.5 High-carbohydrate breakfast −9.38 1.36 −6.89 <.001
Moxifloxacin 4.26 1.36 3.13 .0534
Moxifloxacin + high-carbohydrate breakfast −10.97 1.35 −8.1 <.001
H 0.75 High-carbohydrate breakfast −9.48 1.36 −6.97 <.001
Moxifloxacin 6.99 1.35 5.17 <.001
Moxifloxacin + high-carbohydrate breakfast −9.37 1.35 −6.92 <.001
H 1 High-carbohydrate breakfast −10.69 1.37 −7.82 <.001
Moxifloxacin 7.54 1.36 5.55 <.001
Moxifloxacin + high-carbohydrate breakfast −10.19 1.35 −7.53 <.001
H 1.5 High-carbohydrate breakfast −9.05 1.36 −6.66 <.001
Moxifloxacin 7.57 1.35 5.59 <.001
Moxifloxacin + high-carbohydrate breakfast −7.05 1.35 −5.21 <.001
H 2 High-carbohydrate breakfast −8.95 1.36 −6.58 <.001
Moxifloxacin 6.99 1.36 5.16 <.001
Moxifloxacin + high-carbohydrate breakfast −6.64 1.35 −4.9 <.001
H 2.5 High-carbohydrate breakfast −9 1.37 −6.59 <.001
Moxifloxacin 8.8 1.35 6.5 <.001
Moxifloxacin + high-carbohydrate breakfast −5.28 1.36 −3.88 <.01
H 3 High-carbohydrate breakfast −7.85 1.36 −5.77 <.001
Moxifloxacin 7.55 1.35 5.58 <.001
Moxifloxacin + high-carbohydrate breakfast −3.83 1.35 −2.83 .135
H 3.5 High-carbohydrate breakfast −9.68 1.36 −7.11 <.001
Moxifloxacin 7.77 1.35 5.75 <.001
Moxifloxacin + high-carbohydrate breakfast −2.61 1.35 −1.93 .7936
H 4 High-carbohydrate breakfast −9.46 1.37 −6.92 <.001
Moxifloxacin 5.88 1.36 4.32 <.001
Moxifloxacin + high-carbohydrate breakfast −0.04 1.36 −0.03 >0.9999
H 6 High-carbohydrate breakfast 0.84 1.37 0.61 >0.9999
Moxifloxacin 6.09 1.36 4.49 <.001
Moxifloxacin + high-carbohydrate breakfast 6.41 1.36 4.72 <.001
phosphorylated, enhances Ca2+ entry into the cell.28
It was suggested that norepinephrine mediates
Ca2+ release by a rapid increase in the free Ca2+
concentration near the sarcoplasmic reticulum.29 As a
result of the Ca2+ cycling between the cytoplasm and
the sarcoplasmic reticulum, contractility is increased,
and a greater volume of blood is ejected during systole.
It is important to note that the increases in epinephrine
and norepinephrine plasma levels observed after a meal
are short lasting (90 minutes),24 whereas the QTcF
shortening is consistently present for up to 7 hours
after the start of a meal.30
The main effect of a meal on cardiac repolarization
seen in this study was a shortening of J-Tpeak, which
corresponds to phase 2 and the early part of phase 3
of the cardiac myocyte action potential. Phase 2 of
the action potential is characterized by a number
of ion channels closing and opening. The duration
of phase 2 is influenced in a significant way by the
balance of Ca2+ influx and K+ outflow. We therefore
suggest that the mechanism by which food affects
J-Tpeak may be associated with the signaling pathways
of calcium cycling. This is consistent with the increase
in cardiac stroke volume after a meal, which involves
an increase in Ca2+ release and uptake to and from
the sarcoplasmic reticulum associated with increased
inotropy.
In our previous work, we have shown that a meal
shortens the QTcF interval in the context of a formal
thorough QT study using moxifloxacin as a positive
control to assess assay sensitivity.1 We could reconcile
our findings with previous literature reports suggesting
that meals prolong QTcB: First, these studies looked
only at the first 1 to 2 hours after a meal, when there
is a significant HR increase, and they used Bazett’s HR
correction, which is sensitive to HR changes. We could
replicate these findings from our data. We conducted
a further research study17 to investigate claims by
Gastaldelli et al31 that insulin prolongs QTc. We found
that C-peptide and glucose had antagonistic effects on
the QTc interval. In a healthy individual, the presence
of C-peptide shortens the QTc, and it appears that this
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Table 5. Output of the Mixed Model of Tpeak-Tend (Contrasts on Baseline)
Parameter Estimate
Standard
Error
Degrees of
Freedom (df) T Value P Value 5%CI 95%CI
Baseline −9.72 0.58 30.12 −16.88 <.001 −10.75 −8.55
Treatment Time point
Placebo H 0.25 0.28 2.53 32.16 0.11 .91 −3.76 4.79
H 0.5 0.16 2.53 32.08 0.06 .95 −3.78 4.63
H 0.75 1.08 2.53 32.04 0.43 .67 −2.89 5.58
H 1 1.24 2.53 32.1 0.49 .63 −3.03 5.45
H 1.5 0.93 2.53 32.1 0.37 .71 −3.31 5.48
H 2 0.13 2.53 32.08 0.05 .96 −4.02 4.63
H 2.5 0.07 2.53 32.11 0.03 .98 −3.97 4.67
H 3 0.33 2.53 32.12 0.13 .90 −3.54 4.09
H 3.5 1.71 2.53 32.17 0.68 .50 −2.35 6.80
H 4 0.89 2.53 32.13 0.35 .73 −3.38 5.10
H 6 2.79 2.53 32.25 1.10 .28 −1.18 7.07
Moxifloxacin H 0.25 −0.54 2.53 32.18 −0.21 .83 −4.75 3.49
H 0.5 2.76 2.53 32.14 1.09 .28 −1.24 7.40
H 0.75 4.39 2.53 32.06 1.74 .09 0.52 9.00
H 1 4.33 2.53 32.13 1.71 .10 −0.13 8.47
H 1.5 4.22 2.53 32.1 1.67 .10 −0.21 8.05
H 2 4.11 2.53 32.12 1.63 .11 −0.53 8.46
H 2.5 5.36 2.53 32.12 2.12 <.05 1.02 9.49
H 3 4.96 2.53 32.16 1.96 .06 0.69 9.04
H 3.5 5.29 2.53 32.2 2.09 <.05 1.4 9.06
H 4 5.85 2.53 32.12 2.32 <.05 1.72 9.71
H 6 7.5 2.53 32.25 2.96 <.01 2.82 11.46
High-carbohydrate
Breakfast
H 0.25 2.72 2.53 32.24 1.07 .29 −1.33 6.61
H 0.5 1.55 2.53 32.27 0.61 .55 −2.17 6.06
H 0.75 1.74 2.53 32.18 0.69 .50 −2.47 6.07
H 1 0.05 2.53 32.2 0.02 .99 −4.22 5.02
H 1.5 −0.1 2.53 32.16 −0.04 .97 −4.26 4.42
H 2 −0.92 2.53 32.16 −0.36 .72 −4.94 3.99
H 2.5 0.01 2.53 32.16 0 >.99 −4.62 4.04
H 3 −0.85 2.53 32.14 −0.34 .74 −5.18 2.84
H 3.5 −0.97 2.53 32.16 −0.38 .70 −4.85 4.15
H 4 0.01 2.53 32.15 0 >.99 −4.39 4.69
H 6 1.36 2.53 32.16 0.54 .59 −3.06 6.12
Moxifloxacin +
high-carbohydrate
breakfast
H 0.25 2.39 2.53 32.23 0.94 .35 −1.46 6.88
H 0.5 2.51 2.53 32.2 0.99 .33 −2.34 6.89
H 0.75 2.35 2.53 32.15 0.93 .36 −1.93 7.15
H 1 2.79 2.53 32.17 1.11 .28 −0.89 7.82
H 1.5 1.83 2.53 32.15 0.72 .47 −2.14 6.63
H 2 2.83 2.53 32.11 1.12 .27 −1.22 7.48
H 2.5 2.33 2.53 32.15 0.92 .36 −2.27 6.98
H 3 2.7 2.53 32.1 1.07 .29 −1.62 6.51
H 3.5 4.14 2.53 32.13 1.64 .11 −0.40 9.22
H 4 4.21 2.53 32.16 1.66 .11 −0.47 8.25
H 6 6.47 2.53 32.15 2.56 <.05 2.32 10.05
is offsetting the effect of glucose, which by itself appears
to prolong the QTc interval; this has been described
by others.32 We hypothesized that the net effect of
the 2 antagonistic effects leads to an approximate 8-
millisecond QTc shortening with a peak occurring 2 to
4 hours after starting a meal in a normal individual.
Our analysis also confirmed that insulin in a euglycemic
clamp has no effect on QTcF.7
It has been demonstrated that physiological con-
centrations of C-peptide increase the expression of
erythrocyte Na+/K+-adenosine triphosphatase33 and
induce intracellular Ca2+ increases in human renal
tubular cells,34 making it a reasonable hypothesis that
the same occurrence could be observable in cardiomy-
ocytes. C-peptide was also shown to increase the release
of nitric oxide from endothelial nitric oxide synthase
in bovine aortic endothelial cells in a concentration-
and time-dependent manner. The data indicated that
C-peptide is likely to stimulate the activity of the Ca2+-
sensitive endothelial nitric oxide synthase by increasing
10 The Journal of Clinical Pharmacology / Vol 0 No 0 2019
Table 6. Linear Contrasts Derived From the Mixed Model on Tpeak-Tend
Parameters
Contrast
Time
Point Group Estimate
Standard
Error T Value P Value
Placebo 0.25 High-carbohydrate breakfast 2.43 0.97 2.51 .31
Moxifloxacin −0.82 0.97 −0.85 >.99
Moxifloxacin + high-carbohydrate breakfast 2.11 0.97 2.18 .58
0.5 High-carbohydrate breakfast 2.36 0.97 2.43 .36
Moxifloxacin 2.6 0.97 2.69 .19
Moxifloxacin + high-carbohydrate breakfast 2.35 0.97 2.43 .37
0.75 High-carbohydrate breakfast 1.63 0.97 1.68 .94
Moxifloxacin 3.31 0.96 3.43 <.05
Moxifloxacin + high-carbohydrate breakfast 2.24 0.97 2.32 .46
1 High-carbohydrate breakfast −1.19 0.97 −1.23 >.99
Moxifloxacin 3.09 0.96 3.2 <.05
Moxifloxacin + high-carbohydrate breakfast 1.56 0.97 1.61 .96
1.5 High-carbohydrate breakfast −0.06 0.97 −0.06 >.99
Moxifloxacin 3.28 0.96 3.4 <.05
Moxifloxacin + high-carbohydrate breakfast 0.9 0.97 0.93 >.99
2 High-carbohydrate breakfast −0.08 0.97 −0.08 >.99
Moxifloxacin 3.97 0.97 4.12 <.01
Moxifloxacin + high-carbohydrate breakfast 3.67 0.97 3.8 <.01
2.5 High-carbohydrate breakfast −0.06 0.97 −0.07 >.99
Moxifloxacin 5.28 0.97 5.47 <.001
Moxifloxacin + high-carbohydrate breakfast 3.23 0.96 3.35 <.05
3 High-carbohydrate breakfast −0.21 0.97 −0.22 >.99
Moxifloxacin 4.63 0.97 4.8 <.001
Moxifloxacin + high-carbohydrate breakfast 2.37 0.97 2.46 .34
3.5 High-carbohydrate breakfast −1.71 0.97 −1.77 .90
Moxifloxacin 3.58 0.96 3.71 <.01
Moxifloxacin + high-carbohydrate breakfast 3.4 0.97 3.52 <.05
4 High-carbohydrate breakfast 0.09 0.97 0.09 >.99
Moxifloxacin 5.94 0.97 6.15 <.001
Moxifloxacin + high-carbohydrate breakfast 4.29 0.97 4.44 <.001
6 High-carbohydrate breakfast 0.52 0.97 0.53 >.99
Moxifloxacin 4.71 0.96 4.88 <.001
Moxifloxacin + high-carbohydrate breakfast 4.65 0.97 4.81 <.001
the influx of Ca2+ into endothelial cells.35 Combined,
data suggest that C-peptide may elicit changes in car-
diac repolarization through a potential interaction with
Ca2+ cycling in the cardiac myocyte as one possible
explanation for QTc shortening after a meal. Although
C-peptide has been shown to bind specifically to human
cell membranes36,37 and G-protein coupled receptor
146 was identified as an essential contributor for the C-
peptide signaling complex,38 the receptor of C-peptide
remains unknown. Further investigations are required
to understand the role of C-peptide and determine
the underlying mechanisms of the impact on cardiac
repolarization during the postprandial period.
In summary, this study demonstrates that food exerts
an effect on early repolarization and that an initial
shortening of the J-Tpeak interval was seen with mox-
ifloxacin in the fed state even when the differences in
plasma concentrations are taken into account (data not
shown).
From the analysis presented in this paper, it could be
postulated that some type of relationship might exist
between shortening of J-Tpeak and C-peptide concen-
trations having an effect on Ca2+ cycling in the car-
diomyocyte. Further work will be necessary to unravel
the precise mechanism(s) by which this interplay could
occur.
Limitations
This study has some limitations. This was a retro-
spective analysis and exploratory in nature, as the
technical methods utilized to measure the subintervals
of QTc were unavailable at the time of conducting
the study. However, the analysis is sufficiently robust
regarding the J-Tpeak interval shortening following a
meal, and the results align well with previous published
work. The sample size is relatively small and contains
both females and males. Matsukura et al39 recently
published a report suggesting that males and females
show a different response regarding the J-Tpeak interval.
This has not been explored with this data.
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